(2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine has been researched along with netupitant in 1 studies
Studies ((2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine) | Trials ((2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine) | Recent Studies (post-2010) ((2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine) | Studies (netupitant) | Trials (netupitant) | Recent Studies (post-2010) (netupitant) |
---|---|---|---|---|---|
9 | 0 | 1 | 68 | 19 | 66 |
Protein | Taxonomy | (2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine (IC50) | netupitant (IC50) |
---|---|---|---|
Substance-P receptor | Homo sapiens (human) | 0.001 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvaro, G; Braggio, S; Carletti, R; Corsi, M; Di Fabio, R; Gerrard, PA; Griffante, C; Marchioro, C; Melotto, S; Piccoli, L; Poffe, A; Pozzan, A; Ratti, E; Spada, S; Tranquillini, E; Trower, M | 1 |
1 other study(ies) available for (2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine and netupitant
Article | Year |
---|---|
Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; CHO Cells; Cricetinae; Cricetulus; Dogs; Female; Gerbillinae; Half-Life; Humans; Male; Models, Molecular; Molecular Conformation; Neurokinin-1 Receptor Antagonists; Piperazines; Piperidines; Protein Binding; Rats; Receptors, Neurokinin-1 | 2013 |